BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12497741)

  • 21. Signal transduction. Mating, channels and kidney cysts.
    Emmons SW; Somlo S
    Nature; 1999 Sep; 401(6751):339-40. PubMed ID: 10517627
    [No Abstract]   [Full Text] [Related]  

  • 22. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathophysiology of autosomal dominant polycystic kidney disease].
    Rózański J; Domański L; Myślak M; Ciechanowski K; Szmatłoch E
    Pol Arch Med Wewn; 2000 Aug; 104(2):519-23. PubMed ID: 11303320
    [No Abstract]   [Full Text] [Related]  

  • 24. Common regulatory elements in the polycystic kidney disease 1 and 2 promoter regions.
    Lantinga-van Leeuwen IS; Leonhard WN; Dauwerse H; Baelde HJ; van Oost BA; Breuning MH; Peters DJ
    Eur J Hum Genet; 2005 May; 13(5):649-59. PubMed ID: 15770226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic approach in autosomal dominant polycystic kidney disease.
    Pei Y
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gene diagnosis of autosomal dominant polycystic kidney disease type 2 using microsatellite DNA tightly linked to polycystic kidney disease gene 2].
    Zhang WL; Zhang DY; Wu YM; Sun TM; Mei CL
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):325-8. PubMed ID: 15300626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease.
    Persu A; Devuyst O
    Nephrol Dial Transplant; 2000 Jun; 15(6):747-50. PubMed ID: 10831619
    [No Abstract]   [Full Text] [Related]  

  • 28. Inherited autosomal dominant polycystic kidney disease--genetic polymorphism.
    Karnolski IN
    Folia Med (Plovdiv); 2002; 44(4):7-9. PubMed ID: 12751680
    [No Abstract]   [Full Text] [Related]  

  • 29. Polycystins: what polycystic kidney disease tells us about sperm.
    Kierszenbaum AL
    Mol Reprod Dev; 2004 Apr; 67(4):385-8. PubMed ID: 14991728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polycystins, calcium signaling, and human diseases.
    Delmas P; Padilla F; Osorio N; Coste B; Raoux M; Crest M
    Biochem Biophys Res Commun; 2004 Oct; 322(4):1374-83. PubMed ID: 15336986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Progress in molecular genetics of autosomal dominant polycystic kidney disease.
    Trudel M; Guillaume R
    Front Biosci; 2000 Mar; 5():D312-20. PubMed ID: 10704432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years.
    Dicks E; Ravani P; Langman D; Davidson WS; Pei Y; Parfrey PS
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):710-7. PubMed ID: 17699277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adult dominant polycystic kidney disease: molecular mechanisms and new therapeutic possibilities].
    Rodríguez Pérez JC; Torres MJ
    Nefrologia; 2006; 26(6):651-2. PubMed ID: 17227240
    [No Abstract]   [Full Text] [Related]  

  • 34. KHA-CARI guideline recommendations for the diagnosis and management of autosomal dominant polycystic kidney disease.
    Rangan GK; Alexander SI; Campbell KL; Dexter MA; Lee VW; Lopez-Vargas P; Mai J; Mallett A; Patel C; Patel M; Tchan MC; Tong A; Tunnicliffe DJ; Vladica P; Savige J
    Nephrology (Carlton); 2016 Aug; 21(8):705-16. PubMed ID: 26511892
    [No Abstract]   [Full Text] [Related]  

  • 35. A short carboxy-terminal domain of polycystin-1 reorganizes the microtubular network and the endoplasmic reticulum.
    Gao H; Sellin LK; Pütz M; Nickel C; Imgrund M; Gerke P; Nitschke R; Walz G; Kramer-Zucker AG
    Exp Cell Res; 2009 Apr; 315(7):1157-70. PubMed ID: 19331813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The vasculopathy of autosomal dominant polycystic kidney disease: insights from animal models.
    Arnaout MA
    Kidney Int; 2000 Dec; 58(6):2599-610. PubMed ID: 11115102
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autosomal dominant polycystic kidney disease. Proposal to guidelines for patients and their relatives].
    Ugeskr Laeger; 2004 Oct; 166(43):3807-11. PubMed ID: 15544110
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening for intracranial aneurysms in ADPKD.
    Ong AC
    BMJ; 2009 Sep; 339():b3763. PubMed ID: 19770180
    [No Abstract]   [Full Text] [Related]  

  • 39. Mutations of the PKD2 gene in Taiwanese patients with autosomal dominant polycystic kidney disease.
    Chang MY; Fang JT; Huang CC; Wu IW; Wu Chou YH
    Ren Fail; 2005; 27(1):95-100. PubMed ID: 15717641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease].
    Joly D
    Med Sci (Paris); 2011 Mar; 27(3):249-51. PubMed ID: 21447293
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.